Csl Limited Stock Performance
| CMXHF Stock | USD 175.00 2.81 1.58% |
On a scale of 0 to 100, CSL holds a performance score of 4. The firm shows a Beta (market volatility) of 1.48, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CSL will likely underperform. Please check CSL's total risk alpha, expected short fall, period momentum indicator, as well as the relationship between the value at risk and rate of daily change , to make a quick decision on whether CSL's price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CSL Limited are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical indicators, CSL reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1.7 B | |
| Total Cashflows From Investing Activities | -1.6 B | |
| Free Cash Flow | 1.4 B |
CSL |
CSL Relative Risk vs. Return Landscape
If you would invest 15,731 in CSL Limited on April 27, 2025 and sell it today you would earn a total of 1,769 from holding CSL Limited or generate 11.25% return on investment over 90 days. CSL Limited is currently producing 0.2589% returns and takes up 4.2182% volatility of returns over 90 trading days. Put another way, 37% of traded pink sheets are less volatile than CSL, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CSL Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CSL's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CSL Limited, and traders can use it to determine the average amount a CSL's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0614
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CMXHF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.22 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average CSL is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CSL by adding it to a well-diversified portfolio.
CSL Fundamentals Growth
CSL Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CSL, and CSL fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CSL Pink Sheet performance.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0798 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 96.65 B | |||
| Shares Outstanding | 482.22 M | |||
| Price To Earning | 33.44 X | |||
| Price To Book | 6.65 X | |||
| Price To Sales | 9.30 X | |||
| Revenue | 10.49 B | |||
| EBITDA | 3.46 B | |||
| Cash And Equivalents | 10.44 B | |||
| Cash Per Share | 21.67 X | |||
| Total Debt | 3.86 B | |||
| Debt To Equity | 0.66 % | |||
| Book Value Per Share | 30.26 X | |||
| Cash Flow From Operations | 2.63 B | |||
| Earnings Per Share | 4.80 X | |||
| Total Asset | 28.35 B | |||
| Retained Earnings | 6.59 B | |||
| Current Asset | 3.82 B | |||
| Current Liabilities | 1.37 B | |||
About CSL Performance
By analyzing CSL's fundamental ratios, stakeholders can gain valuable insights into CSL's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CSL has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CSL has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. Csl operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 30000 people.Things to note about CSL Limited performance evaluation
Checking the ongoing alerts about CSL for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CSL Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CSL Limited had very high historical volatility over the last 90 days |
- Analyzing CSL's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CSL's stock is overvalued or undervalued compared to its peers.
- Examining CSL's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CSL's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CSL's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CSL's pink sheet. These opinions can provide insight into CSL's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CSL Pink Sheet analysis
When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |